With multiple gene and protein analysis technologies, we offer unique de novo neoantigen discovery, identification, and selection to get a suitable CAR-T therapy target with high potency and low toxicity.
Learn More →Chimeric Antigen Receptor (CAR) T Cell Design & Manufacturing Service
Creative Biolabs offers comprehensive CAR-T cell design and manufacturing services, including neoantigen identification, scFv generation, CAR design construction, and plasmid GLP production. Our end-to-end solutions cover the entire development process, from transfection and CAR-T preparation to in vitro and in vivo testing. We specialize in creating diverse CAR constructs, such as bispecific, inducible, and oxygen-sensing CARs, providing GLP level to support your research goals. Our expert team ensures customized services, addressing all your CAR-T therapy development needs. If you want to know more about our detailed CAR-T cell design and manufacturing services, please click here for more information.
Introduction What We Can Offer How We Can Help Why Choose Us? Customer Reviews FAQs Related Services Contact Us
Introduction of CAR-T Cell Therapy
CAR-T cell therapy is an advanced form of immunotherapy designed to treat cancer. It involves engineering a patient's T-cells to express a receptor (CAR) that specifically recognizes antigens on tumor cells. This therapy redirects the body's immune system to target and destroy cancer cells, showing substantial promise in hematological malignancies such as B-cell leukemia and lymphoma.
Creative Biolabs supports the development of various CAR generations, including bispecific, inducible, and synNotch CARs, to meet evolving immunotherapy needs, focusing on providing tailored solutions that address both hematological and solid tumors.
Request a Consultation →
Fig.1 The Structure and Mechanism of Action of CAR-T Cells. 1
The Process of CAR-T Cell Design and Manufacturing Available on Creative Biolabs
Creative Biolabs provides an extensive range of CAR-T cell design and manufacturing services, from neoantigen identification and scFv generation to CAR design and plasmid GLP production. Our solutions encompass the full development process, including transfection, CAR-T preparation, and in vitro/in vivo testing. We excel in engineering various CAR constructs, such as bispecific, inducible, and oxygen-sensing CARs, and offer GLP support. With a highly skilled team, we deliver tailored solutions to support all aspects of CAR-T therapy development.
Neoantigen Identification
scFv Generation and Optimization
Aided by our in-house antibody database and various types of libraries including hybridomas, mouse, rabbit and human, plus scFv sequencing and affinity measurement platforms, we are dedicated to generating the most optimized scFv with high affinity and good properties.
Learn More →CAR Design Construction and Plasmid GLP Production
We are capable of designing and constructing different generations of CARs, also various types of engineered CARs are available at Creative Biolabs, such as suicide CAR, inducible CAR, enhanced CAR, bispecific CAR, synNotch CAR, masked CAR, oxygen-sensing CAR, etc.
Learn More →CAR-T Preparation
With various transfection technologies including electroporation, as well as cell transduction through adenovirus, lentivirus retroviral, etc., we offer CAR gene packaging and delivery services for CAR-T cell generation. To facilitate your drug development, GLP level can be achieved to fit your purpose of the project.
Learn More →CAR-T In Vitro Validation
For generated CAR-T products, a wide range of in vitro assays are available to evaluate the efficiency of CAR-T products, including CAR expression validation, CAR-T cell proliferation, cytokine release assay, cytotoxicity assay, etc.
Learn More →CAR-T In Vivo Testing
Once in vitro assays are completed, a series of in vivo testing systems will be performed to evaluate the CAR-T product, including animal models, biodistribution studies, efficacy testing, toxicology assessment, and other GLP compliant assays.
Learn More →How Creative Biolabs' service Can Assist Your Projects
Highlights
With the commitment to being your best CAR-T therapy partner, Creative Biolabs has established the utmost efficient integrated solutions to innovate and accelerate your drug developments for various types of cancers, especially hematologic malignancies. We are willing to provide you with customized CAR-T design and manufacturing services suitable for your multiple requirements, the reasons why we deserve to be chosen including but not limited to:
Unrivaled Expertise
With deep knowledge in oncology, we provide cutting-edge CAR-T solutions backed by decades of therapeutic experience, technical innovation, and a proven history of success.
Multidisciplinary Collaboration
Our team integrates clinicians, hematologists, and specialists to ensure your project benefits from diverse clinical insights, rigorous scientific peer review, and holistic medical oversight.
High-End Customization
We tailor every service to your specific requirements, from initial neoantigen discovery through to final clinical validation, ensuring a unique path for every candidate.
Versatile Immuno-Oncology Options
Beyond CAR-T, we offer vaccines, antibodies, and small molecules designed to stimulate the immune system and eliminate diverse cancers through multiple biological pathways.
Get a Quote →
Customer Reviews
-
Superior Persistence and Fitness
Using Creative Biolabs' CAR T Cell service in our research has significantly improved the long-term surveillance of our candidates in solid tumor models. The enrichment for Tscm cells was a decisive advantage over our previous in-house protocols. - Dr. S**a. L. -
Elimination of Tonic Signaling
The hinge and TM domain optimization provided by Creative Biolabs facilitated our move into aggressive neuroblastoma targets. We observed a significant reduction in premature exhaustion markers compared to our standard IgG4-hinge constructs. - Prof. M**e. K.
FAQs
What is the advantage of your "Smart" CAR (SynNotch) logic gating?
Our logic gating allows for "AND" or "NOT" gates, ensuring the CAR T-cell only activates when it encounters the tumor, significantly reducing the risk of "on-target, off-tumor" toxicity to healthy tissues.
How do you ensure the T-cells don't exhaust prematurely?
We optimize the transmembrane domains to prevent clustering and use specific cytokine cocktails during expansion to maintain a stem-cell memory phenotype (Tscm).
Related Services
CAR NK Cell Design & Manufacturing
Utilizing primary NK cells or cell lines to provide MHC-independent, allogeneic therapies with reduced GvHD and CRS risks.
Learn More →TCR Identification
High-throughput screening and sequencing platforms for the rapid identification of tumor-specific TCR α/β chains from TILs or antigen-specific T cells.
Learn More →How to Contact Us
Come and let Creative Biolabs support your CAR-T therapy breakthrough, please feel free to contact us to get more information and a quote for any CAR-T therapy module.
Reference
- Chen, Yi-Ju et al. "CAR-T: What Is Next?." Cancers vol. 15,3 663. 21 Jan. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers15030663
Download our brochureLoading case studies...
Online Inquiry